Drug Report History #45716
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v8-FR | Version v1-EN | |
|---|---|---|
| Language (Changed) | Updated to: French | Was: English |
| Date Updated (Changed) | Updated to: 2018-06-08 | Was: 2018-04-13 |
| Drug Identification Number | 02468425 | 02468425 |
| Brand name | SHINGRIX | SHINGRIX |
| Common or Proper name | Herpes Zoster vaccine | Herpes Zoster vaccine |
| Company Name | GLAXOSMITHKLINE INC | GLAXOSMITHKLINE INC |
| Ingredients | VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN | VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN |
| Strength(s) | 50MCG | 50MCG |
| Dosage form(s) | SUSPENSION | SUSPENSION |
| Route of administration | INTRAMUSCULAR | INTRAMUSCULAR |
| Packaging size | 1's | 1's |
| Additional packaging sizes | ||
| ATC code | J07BK | J07BK |
| ATC description | ||
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date (Changed) | Updated to: | Was: 2018-05-10 |
| Actual start date (Changed) | Updated to: 2018-04-30 | Was: |
| Estimated end date | 2018-06-15 | 2018-06-15 |
| Actual end date (Changed) | Updated to: 2018-06-06 | Was: |
| Shortage status (Changed) | Updated to: Resolved | Was: Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments (Changed) | Updated to: Most recent supply released May 15, 2018 with limited quantity. SHINGRIX is available in packages of 10. | Was: SHINGRIX is available in packages of 10. |
| Health Canada comments |